Follow RSS for latest reports on this topicNovartis - Market Research and Reports

Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosimilars and consumer health (including over--the-counter medications).

The main pharmaceutical focus is on medications for the following areas of disease; Cardiovascular and Metabolism, Oncology (including Hematology), Neuroscience and Ophthalmics, Respiratory and Immunology and Infectious Diseases; and the portfolio contains over 50 key products. 147 products are in the pipeline.

Over 20 vaccines have been developed by Novartis, including influenza, meningitis, polio and tetanus, and the company is also developing diagnostic mechanisms for blood and protection of possible blood infections, which is used by 80% of US blood banks.  Sandoz, a sub-group, has a broad portfolio helping to make affordable, high-quality medicines available to patients around the world and stabilize healthcare systems.

Source; BioPortfolio.com and Novartis.com

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...



or can supply a pro-forma invoice if required.

Related Reports:

We found 34 reports that matched your search.

Refine your search, and find more matches, using the form above.

Cardiovascular Drugs Market Global Report 2017 Including: Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs) Covering: Bristol-Myers Squibb Company, Abbott Laboratories Inc., AstraZeneca PLC, Bayer AG, and Novartis AG [Report Updated: 17-07-2017]

Cardiovascular disorders drug market covers the drugs used to treat conditions that affect heart or blood vessels. These conditions include heart stroke, coronary artery diseases, valvular diseases, peripheral venous diseases, pericarditis, endocarditis, cardiac tumors, arteriosclerosis, and lymphatic diseases. Some of the major cardiovascular drugs include anticoagulants such as Rivaroxaban (Xarelto), Dabigatran (Pradaxa), Apixaban (Eliquis),Read More >>>

Published:
2017-07-17

Published by: The Business Research Company

Prices Starting From:
$4000

Published:
2017-07-17

Published by: The Business Research Company

Prices Starting From:
$4000

Published:
2017-07-17

Published by: The Business Research Company

Prices Starting From:
$4000

Published:
2017-07-17

Published by: The Business Research Company

Prices Starting From:
$4000

Ophthalmic Devices Market Global Report 2017 Including: Vision Care Devices, Cataract Surgery Devices , Refractive Surgery Devices, Diagnostic And Monitoring Ophthalmic Devices Covering: Essilor International, Alcon (Novartis), Johnson & Johnson, Hoya Corporation, and Coopervision AG [Report Updated: 17-07-2017]

Ophthalmic devices are an aid in the diagnosis, monitoring, surgery and treatment of various eye related diseases such as cataract, age-related macular degeneration, glaucoma, diabetic retinopathy, retinal detachment or tear, eye infections, dry eye syndrome and others. Companies in this ophthalmic device market engage in the manufacturing of a wide range of products such as contact lenses, glasses, intraocular lenses, diagnostics, retinal impRead More >>>

Published:
2017-07-17

Published by: The Business Research Company

Prices Starting From:
$6000

Ophthalmic Devices Market Global Briefing 2017 Including: Vision Care Devices, Cataract Surgery Devices , Refractive Surgery Devices, and Diagnostic and Monitoring Ophthalmic Devices Covering: Essilor International, Alcon (Novartis), Johnson & Johnson, Abbott Medical, and Carl Zeiss AG [Report Updated: 06-02-2017]

Ophthalmic devices are an aid in the diagnosis, monitoring, surgery and treatment of various eye related diseases such as cataract, age-related macular degeneration, glaucoma, diabetic retinopathy, retinal detachment or tear, eye infections, dry eye syndrome and others. Companies in this ophthalmic device market engage in the manufacturing of a wide range of products such as contact lenses, glasses, intraocular lenses, diagnostics, retinal impRead More >>>

Published:
2017-02-06

Published by: The Business Research Company

Prices Starting From:
$1000

Published:
2016-11-01

Published by: Current Partnering

Prices Starting From:
$1495

We Stock...

{STICKYFOOTERMOBILE}